{"organizations": [], "uuid": "a2a75f8c6c18089ae0ab1293e870448ea26edf48", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-elanco-aratana-announce-marketing/brief-elanco-aratana-announce-marketing-authorization-of-galliprant-in-europe-idUSFWN1P60FS", "country": "US", "domain_rank": 408, "title": "Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.543, "site_type": "news", "published": "2018-01-11T21:25:00.000+02:00", "replies_count": 0, "uuid": "a2a75f8c6c18089ae0ab1293e870448ea26edf48"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-elanco-aratana-announce-marketing/brief-elanco-aratana-announce-marketing-authorization-of-galliprant-in-europe-idUSFWN1P60FS", "ord_in_thread": 0, "title": "Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe", "locations": [], "entities": {"persons": [{"name": "elanco", "sentiment": "negative"}], "locations": [{"name": "europe", "sentiment": "none"}], "organizations": [{"name": "aratana announce marketing authorization of galliprant in europe", "sentiment": "negative"}, {"name": "aratana therapeutics inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 11, 2018 / 1:25 PM / Updated 13 minutes ago BRIEF-Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe Reuters Staff 1 Min Read \nJan 11 (Reuters) - Aratana Therapeutics Inc: \n* ELANCO, ARATANA ANNOUNCE MARKETING AUTHORIZATION OF GALLIPRANTÂ® (GRAPIPRANT TABLETS) IN EUROPE Source text for Eikon: Further company coverage:", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T21:25:00.000+02:00", "crawled": "2018-01-11T15:45:02.007+02:00", "highlightTitle": ""}